Seasonality of restless legs syndrome: symptom variability in winter and summer times.


Journal

Sleep medicine
ISSN: 1878-5506
Titre abrégé: Sleep Med
Pays: Netherlands
ID NLM: 100898759

Informations de publication

Date de publication:
02 2020
Historique:
received: 24 05 2019
revised: 14 07 2019
accepted: 29 07 2019
pubmed: 27 11 2019
medline: 20 4 2021
entrez: 27 11 2019
Statut: ppublish

Résumé

Restless legs syndrome (RLS) is a common sensorimotor neurological disorder, with symptoms that might cause sleep fragmentation leading to excessive daytime sleepiness. A seasonality of RLS symptoms has been suggested; however, to date, no study focused on this aspect. In order to detect a possible seasonality of RLS manifestations, we evaluated RLS symptom severity and excessive daytime sleepiness in winter and summer in RLS patients. RLS patients who performed two follow-up visits in summer and winter were included in this retrospective bicentric analysis. RLS severity, measured with the International RLS Study Group rating scale (IRLS), and daytime sleepiness, measured with the Epworth Sleepiness Scale (ESS), were recorded in both seasons in Innsbruck and Rome Sleep Medicine Centers. In sum, 64 RLS patients were included. In the overall sample, IRLS in summer was higher than in winter (p = 0.008). After gender stratification, this held true only in men (p = 0.008). When stratifying for centers, the seasonal variation in RLS severity was present exclusively in Rome (p < 0.001). Moreover, 20 RLS patients completed ESS in both seasonal periods, and scores in summer were higher than in winter (p < 0.001). This retrospective observational study showed an increase of RLS severity during summer compared to winter, supporting the hypothesis that RLS symptoms are more troublesome when temperatures are higher. Changes in microvascular regulation, sweating, and serum iron level changes may support this difference in RLS symptoms across the year. The documented seasonal variation in RLS severity with worsening in the warmer months needs to be investigated further in prospective studies.

Identifiants

pubmed: 31770614
pii: S1389-9457(19)30269-2
doi: 10.1016/j.sleep.2019.07.026
pii:
doi:

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

10-14

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Claudio Liguori (C)

Sleep Medicine Centre, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy; UOC Neurologia, University Hospital of Rome Tor Vergata, Rome, Italy. Electronic address: dott.claudioliguori@yahoo.it.

Evi Holzknecht (E)

Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.

Fabio Placidi (F)

Sleep Medicine Centre, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy; UOC Neurologia, University Hospital of Rome Tor Vergata, Rome, Italy.

Francesca Izzi (F)

Sleep Medicine Centre, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy; UOC Neurologia, University Hospital of Rome Tor Vergata, Rome, Italy.

Nicola Biagio Mercuri (NB)

UOC Neurologia, University Hospital of Rome Tor Vergata, Rome, Italy; IRCCS Fondazione Santa Lucia, Rome, Italy.

Birgit Högl (B)

Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.

Ambra Stefani (A)

Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH